SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905718-20-001050
Filing Date
2020-10-16
Accepted
2020-10-16 16:05:12
Documents
2
Group Members
ABINGWORTH BIOVENTURES VII, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D spruce_13oct142020.htm SC 13D 51646
2 EX-1 spruce_13oct142020ex1.htm EX-1 9265
  Complete submission text file 0000905718-20-001050.txt   62411
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91764 | Film No.: 201244032
SIC: 2834 Pharmaceutical Preparations